Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop) European Union - English - EMA (European Medicines Agency)

irbesartan hydrochlorothiazide zentiva (previously irbesartan hydrochlorothiazide winthrop)

sanofi-aventis groupe  - irbesartan, hydrochlorothiazide - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension. this fixed-dose combination is indicated in adult patients whose blood pressure is not adequately controlled on irbesartan or hydrochlorothiazide alone.

STADA IRBESARTAN HCT 300/25 irbesartan/hydrochlorothiazide 300 mg/25 mg tablet blister Australia - English - Department of Health (Therapeutic Goods Administration)

stada irbesartan hct 300/25 irbesartan/hydrochlorothiazide 300 mg/25 mg tablet blister

medis pharma pty ltd - hydrochlorothiazide, quantity: 25 mg; irbesartan, quantity: 300 mg - tablet - excipient ingredients: colloidal anhydrous silica; hydrogenated castor oil; microcrystalline cellulose; maize starch; magnesium stearate; lactose monohydrate; croscarmellose sodium; povidone - stada irbesartan hct is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

IRBESARTAN/HCT SANDOZ 300/12.5 irbesartan 300 mg/hydrochlorothiazide 12.5 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

irbesartan/hct sandoz 300/12.5 irbesartan 300 mg/hydrochlorothiazide 12.5 mg film-coated tablet blister pack

sandoz pty ltd - irbesartan, quantity: 300 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: magnesium stearate; hypromellose; lactose monohydrate; hyprolose; titanium dioxide; croscarmellose sodium; colloidal anhydrous silica; macrogol 6000; purified talc; microcrystalline cellulose; iron oxide red; iron oxide yellow - irbesartan/hct sandoz is indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Irbesartan/Hydrochlorothiazide Teva European Union - English - EMA (European Medicines Agency)

irbesartan/hydrochlorothiazide teva

teva b.v.  - irbesartan, hydrochlorothiazide - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension. this fixed-dose combination is indicated in adult patients whose blood pressure is not adequately controlled on irbesartan or hydrochlorothiazide alone.

Irbesartan/Hydrochlorothiazide LAPL 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

irbesartan/hydrochlorothiazide lapl 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablet blister pack

lupin australia pty limited - irbesartan, quantity: 150 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; mannitol; magnesium stearate; crospovidone; povidone; poloxamer; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 3350; iron oxide black; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; ethanol; shellac; sulfuric acid - irbesartan/hctz tablets are indicated for the following:treatment of hypertension.treatment should not be initiated with this fixed-dose combination.

Irbesartan/Hydrochlorothiazide LAPL 300/12.5 irbesartan 300 mg and hydrochlorothiazide 12.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

irbesartan/hydrochlorothiazide lapl 300/12.5 irbesartan 300 mg and hydrochlorothiazide 12.5 mg tablet blister pack

lupin australia pty limited - irbesartan, quantity: 300 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: crospovidone; poloxamer; colloidal anhydrous silica; povidone; mannitol; magnesium stearate; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 3350; iron oxide black; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; ethanol; shellac; sulfuric acid - irbesartan/hctz tablets are indicated for the following:treatment of hypertension.treatment should not be initiated with this fixed-dose combination.

APO-IRBESARTAN HCTZ 300/25 irbesartan and hydrochlorothiazide 300/25mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-irbesartan hctz 300/25 irbesartan and hydrochlorothiazide 300/25mg tablet blister pack

arrotex pharmaceuticals pty ltd - irbesartan, quantity: 300 mg; hydrochlorothiazide, quantity: 25 mg - tablet, film coated - excipient ingredients: lactose monohydrate; povidone; croscarmellose sodium; magnesium stearate; iron oxide yellow; iron oxide red; titanium dioxide; hypromellose; macrogol 4000; iron oxide black - for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Irbesartan HCT GH 300/12.5 irbesartan 300 mg and hydrochlorothiazide 12.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

irbesartan hct gh 300/12.5 irbesartan 300 mg and hydrochlorothiazide 12.5 mg tablet blister pack

lupin australia pty limited - hydrochlorothiazide,irbesartan -

Irbesartan HCT GH 300/25 irbesartan 300 mg and hydrochlorothiazide 25 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

irbesartan hct gh 300/25 irbesartan 300 mg and hydrochlorothiazide 25 mg tablet blister pack

lupin australia pty limited - hydrochlorothiazide,irbesartan -

Irbesartan HCT GH 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

irbesartan hct gh 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablet blister pack

lupin australia pty limited - hydrochlorothiazide,irbesartan -